Ain Shams University: Hepatitis C trials

The registry lists 12 Hepatitis C studies with Ain Shams University as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 4Phase 3 4Phase 4 3No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Pharmacokinetics of Sofosbuvir/Daclatasvir in HCV-infected Lactating WomenStatus unknownNCT04852614
• PK of SOF/LED in HCV - Infected Adolescents With Haematological DisordersStatus unknownNCT04353986Phase 3
• Metabolic Changes in Chronic HCV Patients Receiving DAASStatus unknownNCT04211844
• Pharmacokinetics of Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological MalignancyCompletedNCT03903185Phase 1/2
• Recurrence Rate of Hepatocellular Carcinoma After Treatment of Chronic Hepatits C Patients With Direct Acting Antivirals: Randomized Controlled Phase 3 TrialStatus unknownNCT03551444Phase 3
• Clinical Pharmacokinetics of Daclatasvir/Sofosbuvir in Adolescents With Hepatitis C VirusStatus unknownNCT03540212Phase 2/3
• Statins in Chronic Hepatitis C Patients Receiving Sofosbuvir/Daclatasvir CombinationCompletedNCT03490097Phase 2/3
• Serum Pentraxin-3 in Non-alcoholic Fatty Liver Disease With or Without Hepatitis C VirusCompletedNCT03276039
• Early Treatment of Recurrent HCV- Infection Post Liver Transplantation in the Era of DAAsCompletedNCT03133065Phase 4
• Efficacy and Safety of Qurevo Plus Ribavirin Based Therapy for Hepatitis C With or Without Cirrhosis in Haemodialysis PatientsStatus unknownNCT03067883Phase 2
• Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis Genotype 4CompletedNCT00277862Phase 4
• Timing and Duration of Acute Hepatitis C TreatmentCompletedNCT00241618Phase 4